By exploring the interplay between autophagy, eNOS activity, and NO bioavailability, we seek to uncover chloroquine’s potential to reverse endothelial dysfunction and attenuate pulmonary vascular remodeling. Here, NOS3 is linked to endothelial dysfunction.